Maxime Fontanilles

766 total citations
31 papers, 480 citations indexed

About

Maxime Fontanilles is a scholar working on Genetics, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maxime Fontanilles has authored 31 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 17 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maxime Fontanilles's work include Glioma Diagnosis and Treatment (17 papers), Cancer Genomics and Diagnostics (13 papers) and Cancer Cells and Metastasis (4 papers). Maxime Fontanilles is often cited by papers focused on Glioma Diagnosis and Treatment (17 papers), Cancer Genomics and Diagnostics (13 papers) and Cancer Cells and Metastasis (4 papers). Maxime Fontanilles collaborates with scholars based in France, Italy and Belgium. Maxime Fontanilles's co-authors include Vianney Gilard, Frédéric Di Fiore, Florian Clatot, Florent Marguet, Stéphane Derrey, Annie Laquerrière, Ahmed Idbaïh, Alberto Durán-Peña, Fabrice Jardin and Florent Marguet and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Maxime Fontanilles

29 papers receiving 473 citations

Peers

Maxime Fontanilles
Alfred Yung United States
Jacquelyn J. Roth United States
Meera Nandhabalan United Kingdom
S. Gururangan United States
Joseph D. DiDomenico United States
Maxime Fontanilles
Citations per year, relative to Maxime Fontanilles Maxime Fontanilles (= 1×) peers Marc Barritault

Countries citing papers authored by Maxime Fontanilles

Since Specialization
Citations

This map shows the geographic impact of Maxime Fontanilles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Fontanilles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Fontanilles more than expected).

Fields of papers citing papers by Maxime Fontanilles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Fontanilles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Fontanilles. The network helps show where Maxime Fontanilles may publish in the future.

Co-authorship network of co-authors of Maxime Fontanilles

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Fontanilles. A scholar is included among the top collaborators of Maxime Fontanilles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Fontanilles. Maxime Fontanilles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alexandru, Cristina, Isabelle Tennevet, Olivier Langlois, et al.. (2024). Prognostic value of circulating short-length DNA fragments in unresected glioblastoma patients. Translational Oncology. 42. 101897–101897. 1 indexed citations
2.
Fontanilles, Maxime, Frédéric Di Fiore, Florent Marguet, et al.. (2024). Metabolic remodeling in glioblastoma: a longitudinal multi-omics study. Acta Neuropathologica Communications. 12(1). 162–162. 6 indexed citations
3.
Zhou, Tongxue, et al.. (2023). Prediction of brain tumor recurrence location based on multi-modal fusion and nonlinear correlation learning. Computerized Medical Imaging and Graphics. 106. 102218–102218. 14 indexed citations
4.
Clatot, Florian, F. Douvrin, Justine Lequesne, et al.. (2022). Impact of preoperative staging with contrast-enhanced mammography for localized breast cancer management. British Journal of Radiology. 95(1134). 20210765–20210765. 7 indexed citations
5.
Sarafan‐Vasseur, Nasrin, Ludivine Beaussire, Florent Marguet, et al.. (2022). Impact of EGFRA289T/V mutation on relapse pattern in glioblastoma. ESMO Open. 8(1). 100740–100740. 6 indexed citations
6.
Fontanilles, Maxime, Florent Marguet, Ludivine Beaussire, et al.. (2022). Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma. Revue Neurologique. 178(9). 975–980. 4 indexed citations
7.
Gilard, Vianney, Florent Marguet, Maxime Fontanilles, et al.. (2021). Integrative Metabolomics Reveals Deep Tissue and Systemic Metabolic Remodeling in Glioblastoma. Cancers. 13(20). 5157–5157. 14 indexed citations
8.
Gilard, Vianney, Abdellah Tebani, Ivana Dabaj, et al.. (2021). Diagnosis and Management of Glioblastoma: A Comprehensive Perspective. Journal of Personalized Medicine. 11(4). 258–258. 45 indexed citations
9.
Fontanilles, Maxime, et al.. (2021). Place des biopsies liquides dans le diagnostic et la caractérisation moléculaire des cancers du sein. Bulletin du Cancer. 108(11). 11S46–11S54.
10.
Perdrix, Anne, Justine Lequesne, Maxime Fontanilles, et al.. (2021). Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients. Scientific Reports. 11(1). 24041–24041. 4 indexed citations
11.
Perdrix, Anne, Justine Lequesne, Maxime Fontanilles, et al.. (2020). 265P Circulating PIK3CA mutation detection at diagnosis in non-metastatic inflammatory breast cancer patients. Annals of Oncology. 31. S344–S345. 1 indexed citations
12.
Fontanilles, Maxime, Florent Marguet, Ludivine Beaussire, et al.. (2020). Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma. Acta Neuropathologica Communications. 8(1). 179–179. 36 indexed citations
13.
Fontanilles, Maxime, Nathalie Massy, Tony Pereira, et al.. (2020). Deleterious impact of a generic temozolomide formulation compared with brand‐name product on the kinetic of platelet concentration and survival in newly diagnosed glioblastoma. Fundamental and Clinical Pharmacology. 34(4). 484–494. 2 indexed citations
14.
Fontanilles, Maxime, Florent Marguet, Ludivine Beaussire, et al.. (2020). 371MO Usefulness of circulating tumour DNA detection from cerebrospinal fluid in recurrent high-grade glioma. Annals of Oncology. 31. S400–S400. 1 indexed citations
15.
Fontanilles, Maxime, Florent Marguet, Philippe Ruminy, et al.. (2020). Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma. Acta Neuropathologica Communications. 8(1). 52–52. 9 indexed citations
16.
Gilard, Vianney, et al.. (2019). Stereotactic brain biopsy: evaluation of robot-assisted procedure in 60 patients. Acta Neurochirurgica. 161(3). 545–552. 30 indexed citations
17.
Marguet, Florent, Ludivine Beaussire, Christophe Peillon, et al.. (2019). TERTp Mutation Detection in Plasma by Droplet-Digital Polymerase Chain Reaction in Spinal Myxopapillary Ependymoma with Lung Metastases. World Neurosurgery. 130. 405–409. 9 indexed citations
19.
Fontanilles, Maxime, Alberto Durán-Peña, & Ahmed Idbaïh. (2018). Liquid Biopsy in Primary Brain Tumors: Looking for Stardust!. Current Neurology and Neuroscience Reports. 18(3). 13–13. 37 indexed citations
20.
Fontanilles, Maxime, Florent Marguet, Cristina Alexandru, et al.. (2018). Early platelet variation during concomitant chemo-radiotherapy predicts adjuvant temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma patients. Supportive Care in Cancer. 27(2). 477–484. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026